{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:23:55Z","timestamp":1783056235712,"version":"3.54.6"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.cgh.2017.06.040","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T14:15:42Z","timestamp":1498572942000},"page":"1908-1914.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Treatment With Biologic Agents Has Not Reduced Surgeries\u00a0Among Patients With Crohn\u2019s Disease With Short\u00a0Bowel Syndrome"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2714-6934","authenticated-orcid":false,"given":"Berkeley N.","family":"Limketkai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9995-7942","authenticated-orcid":false,"given":"Alyssa M.","family":"Parian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9865-1009","authenticated-orcid":false,"given":"Po-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fr\u00e9deric","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2017.06.040_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/j.gastro.2016.09.046","article-title":"Management strategies to improve outcomes of patients with inflammatory bowel diseases","volume":"152","author":"Colombel","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.06.040_bib2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2017.06.040_bib3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/ajg.2016.236","article-title":"The real-world effectiveness and safety of vedolizumab for moderate-severe crohn's disease: results from the US VICTORY Consortium","volume":"111","author":"Dulai","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.06.040_bib4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/MIB.0000000000000698","article-title":"Short bowel syndrome and intestinal failure in Crohn's disease","volume":"22","author":"Limketkai","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2017.06.040_bib5","series-title":"HCUP Facts and Figures: Statistics on Hospital-Based Care in the United States, 2009","author":"Wier LM","year":"2011"},{"key":"10.1016\/j.cgh.2017.06.040_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.cgh.2017.06.040_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cgh.2017.06.040_bib8","series-title":"Final Report on Calculating Nationwide Inpatient Sample (NIS) Variances, 2001\u20132005","author":"Houchens","year":"2015"},{"key":"10.1016\/j.cgh.2017.06.040_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/SLA.0b013e3181e61df5","article-title":"Trends in surgery for Crohn's disease in the era of infliximab","volume":"252","author":"Jones","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.cgh.2017.06.040_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/ecco-jcc\/jjv190","article-title":"Impact of new treatments on hospitalisation, surgery, infection, and mortality in IBD: a focus paper by the epidemiology Committee of ECCO","volume":"10","author":"Annese","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2017.06.040_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ajg.2014.45","article-title":"Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy","volume":"109","author":"Vester-Andersen","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.06.040_bib12","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/gutjnl-2013-305607","article-title":"Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011","volume":"63","author":"Rungoe","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.06.040_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.06.040_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2017.06.040_bib15","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/ajg.2010.78","article-title":"Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data","volume":"105","author":"Schreiber","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.06.040_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.crohns.2012.05.015","article-title":"Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease","volume":"7","author":"Schreiber","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2017.06.040_bib17","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0140-6736(15)00068-9","article-title":"Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial","volume":"386","author":"Khanna","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2017.06.040_bib18","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/ajg.2013.248","article-title":"Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate","volume":"108","author":"Schoepfer","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.06.040_bib19","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.cgh.2013.12.035","article-title":"Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence","volume":"12","author":"Regueiro","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.06.040_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.06.040_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjmed.2010.08.017","article-title":"Trends in comorbidity, disability, and polypharmacy in heart failure","volume":"124","author":"Wong","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2017.06.040_bib22","first-page":"689","article-title":"HIV surveillance\u2013United States, 1981-2008","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cgh.2017.06.040_bib23","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1365-2036.2006.02918.x","article-title":"Declining incidence of peptic ulcer but not of its complications: a nation-wide study in the Netherlands","volume":"23","author":"Post","year":"2006","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517307875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517307875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:24:01Z","timestamp":1761542641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356517307875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1542356517307875"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2017.06.040","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment With Biologic Agents Has Not Reduced Surgeries\u00a0Among Patients With Crohn\u2019s Disease With Short\u00a0Bowel Syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2017.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}